| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.2 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.093 | 0.2 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |